"It's relaxing, in a way," says Joan, 78, who was diagnosed with early-stage Alzheimer's disease two years ago. "I just kind of sit there."
"A lot of people just said, 'This is too good to be true. This cannot be real,'" Tsai says, highlighting the skepticism surrounding their findings.
"So far, the results have provided encouraging evidence of neuroprotection, with none of the serious side effects, such as brain swelling or bleeding..." said Allan Levey.
"To prove her critics wrong, she realized she needed human data," highlighting the necessity of rigorous testing in the field of Alzheimer’s research.
Collection
[
|
...
]